Visual Morbidity in Giant Cell Arteritis:Clinical Characteristics and Prognosis for Vision
Ophthalmology 101:1779-1785, Liu,G.T.,et al, 1994
Looking Beyond the Usual
Delhi J Ophthal doi:7869/djo.555, Shakrawal, J.,et al, 2020
Natalizumab Reduces Visual Loss in Patients with Relapsing Multiple Sclerosis
Neurol 68:1299-1302, Balcer,L.J.,et al, 2007
Clinical Characteristics of African Americans vs Caucasian Americans with Multiple Sclerosis
Neurol 63:2039-2045, Bree,B.A.C.,et al, 2004
A Randomized Controlled Study of the Acute and Chronic Effects of Cooling Therapy for MS
Neurol 60:1955-1960, NASA/MS Cooling Study Group, 2003
Fomepizole for the Treatment of Methanol Poinsoning
NEJM 344:424-429, Brent,J.,et al, 2001
Optic Neuritis in African Americans
Arch Neurol 55:186-192, Phillips,P.H.,et al, 1998
Effects of Weight Loss on the Course of Idiopathic Intracranial Hypertension in women
Neurol 50:1094-1098, Kupersmith,M.J.,et al, 1998
Optic Nerve Sheath Fenestration for Pseudotumor Cerebri
J Neuro-Ophthalmol 17:86-91, Goh,K.Y.,et al, 1997
Required Vision Testing for Older Drivers
NEJM 326:1784-1785, Nelson,D.E.,et al, 1992
Lidocaine Unmasks Silent Demyelinative Lesions in Multiple Sclerosis
Neurol 42:2088-2093, Sakurai,M.,et al, 1992
Visual Improvement with SMS 201-995 in a Patient with a Thyrotropin-Secreting Pituitary Adenoma
NEJM 317:53-54, Guillaussea,P.J.,et al, 1987